Christopher Mutz
Corporate Officer/Principal en ANI PHARMACEUTICALS, INC. .
Fortuna: 5 M $ al 30/04/2024
Perfil
Christopher K.
Mutz is currently the Senior Vice President & Head-Rare Diseases at ANI Pharmaceuticals, Inc. Previously, he worked as the National Sales Director-US Metabolic Business Unit at Alexion Pharmaceuticals, Inc. He completed his undergraduate degree at the University of Virginia and holds an MBA from the Johnson Graduate School of Management.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 21/05/2024 | 83 277 ( 0.40% ) | 5 M $ | 30/04/2024 |
Cargos activos de Christopher Mutz
| Empresas | Cargo | Inicio |
|---|---|---|
| ANI PHARMACEUTICALS, INC. | Corporate Officer/Principal | 17/02/2021 |
Antiguos cargos conocidos de Christopher Mutz.
| Empresas | Cargo | Fin |
|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formación de Christopher Mutz.
| University of Virginia | Undergraduate Degree |
| Johnson Graduate School of Management | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ANI PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Christopher Mutz
